Juan Jacob Strouse

Title: Juan Jacob Strouse: Innovator in Cancer Treatment

Introduction

Juan Jacob Strouse is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer. His innovative work focuses on selective efflux inhibitors that target cancer-associated transporter proteins.

Latest Patents

Strouse holds a patent for "Selective efflux inhibitors and related pharmaceutical compositions and methods of treatment." This invention provides pyrazolo[1,5-a]pyrimidine compounds that inhibit cancer-associated transporter proteins. The methods outlined in the patent aim to treat or prevent diseases mediated by these proteins. Specifically, the invention includes efflux inhibitors that are selective toward ABCG2 over ABCB1. These compounds may be utilized to treat various forms of cancer, including drug-resistant and multiple drug-resistant cancers. Strouse's patent is a testament to his commitment to advancing cancer treatment options.

Career Highlights

Throughout his career, Juan Jacob Strouse has worked with reputable institutions such as STC.UNM and the University of Kansas Medical Center Research Institute. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Strouse has collaborated with notable colleagues, including Richard Smith Larson and Larry A Sklar. These partnerships have enriched his research and expanded the impact of his innovations in cancer treatment.

Conclusion

Juan Jacob Strouse is a dedicated inventor whose work in selective efflux inhibitors has the potential to transform cancer treatment. His innovative approach and collaborations with esteemed institutions and colleagues highlight his significant contributions to the field.